135306-46-6Relevant articles and documents
MONOAM1NE REUPTAKE INHIBITORS
-
Page/Page column 72, (2010/11/04)
The invention provides bupropion analogue compounds capable of inhibiting the reuptake of one or more monoamines. The compounds may selectively bind to one or more monoamine transporters, including those for dopamine, norepinephrine,and serotonin. Such compounds may be used to treat conditions that are responsive to inhibition of the reuptake of monoamines, including addiction, depression, and obesity
(2S,3S,5R)-2-(3,5-difluorophenyl)-3,5-dimethyl-2-morpholinol: a novel antidepressant agent and selective inhibitor of norepinephrine uptake.
Kelley, James L.,Musso, David L.,Boswell, G. Evan,Soroko, Francis E.,Cooper, Barrett R.
, p. 347 - 349 (2007/10/03)
(2S,3S,5R)-2-(3,5-difluorophenyl)-3,5-dimethyl-2-morpholinol: a novel antidepressant agent and selective inhibitor of norepinephrine uptake.